AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10980064 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotopic liver transplantation (OLT)
Number of subjects: 32
Study 10980064 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonalcoholic cirrhosis)
Number of subjects: 32
Study 10980064 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 32
Study 8991562 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatics at high altitude (3200m)
Number of subjects: 24
Study 8991562 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls at high altitude (3200m)
Number of subjects: 24
Study 8991562 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatics after acclimatization at high altitude
Number of subjects: 24
Study 8991562 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls after acclimatization at high altitude
Number of subjects: 24
Study 1538610 — intervention group
Group type: EXPERIMENTAL
Intervention: Transportation incentives (bus passes/parking permits)
Number of subjects: 2000
Study 1538610 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized follow-up letter and pamphlet + Slide-tape program
Number of subjects: 2000
Study 6735569 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary method
Number of subjects: 310
Study 6735569 — intervention group
Group type: COMPARATOR
Intervention: 24-hour recall method
Number of subjects: 310
Study 6735569 — intervention group
Group type: COMPARATOR
Intervention: One-week recall method
Number of subjects: 310
Study 30456796 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 250
Study 30456796 — intervention group
Group type: COMPARATOR
Intervention: Basal-bolus insulin
Number of subjects: 250
Study 29361153 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher pain severity (4, 6, 8/10)
Number of subjects: 109
Study 29361153 — intervention group
Group type: EXPERIMENTAL
Intervention: Low medical evidence
Number of subjects: 109
Study 29361153 — intervention group
Group type: EXPERIMENTAL
Intervention: High medical evidence
Number of subjects: 109
Study 29361153 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 109
Study 25601016 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping(®)
Number of subjects: 47
Study 25601016 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 47
Study 25601016 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 22911637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-detected abnormal adnexal morphology
Number of subjects: 4367
Study 22911637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-detected abnormal adnexal morphology with solid elements
Number of subjects: 4367
Study 22911637 — intervention group
Group type: COMPARATOR
Intervention: Normal annual scans throughout the 3-year follow-up period
Number of subjects: 4367
Study 20525211 — intervention group
Group type: EXPERIMENTAL
Intervention: A allele of the angiotensin II type 1 receptor
Number of subjects: 1379
Study 20525211 — intervention group
Group type: EXPERIMENTAL
Intervention: Combinations of polymorphisms of two or all three genes
Number of subjects: 1379
Study 18195313 — intervention group
Group type: EXPERIMENTAL
Intervention: Care managers assisting with primary care connections
Number of subjects: 175
Study 18195313 — intervention group
Group type: EXPERIMENTAL
Intervention: Care managers
Number of subjects: 175
Study 18195313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no care managers)
Number of subjects: 175
Study 16444035 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro‐muscular electric stimulation (NMES) in addition to standard rehabilitation regimen
Number of subjects: 43
Study 16444035 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation regimen (Control)
Number of subjects: 43
Study 12574224 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients before treatment
Number of subjects: 17
Study 12574224 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients during treatment
Number of subjects: 17
Study 12574224 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyroid patients after treatment
Number of subjects: 17
Study 12574224 — intervention group
Group type: COMPARATOR
Intervention: All study groups during clamp
Number of subjects: 17
Study 10362951 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic nursing intervention for breathlessness management
Number of subjects: 0
Study 10362951 — intervention group
Group type: EXPERIMENTAL
Intervention: Course to teach the breathlessness intervention
Number of subjects: 0
Study 8867434 — intervention group
Group type: EXPERIMENTAL
Intervention: iomeprol 350 mg/ml
Number of subjects: 29
Study 8867434 — intervention group
Group type: COMPARATOR
Intervention: iopentol 350 mg/ml
Number of subjects: 29
Study 1653674 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (0.15 units/kg)
Number of subjects: 8
Study 1653674 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 8
Study 3880557 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily, morning dosage at 9 am for 5 days)
Number of subjects: 8
Study 3880557 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg daily, evening dosage at 9 pm for 5 days)
Number of subjects: 8
Study 3880557 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (morning dosage)
Number of subjects: 8
Study 3880557 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (evening dosage)
Number of subjects: 8
Study 31144484 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprapubic tube (SPT)
Number of subjects: 191
Study 31144484 — intervention group
Group type: COMPARATOR
Intervention: Urethral catheter (UC)
Number of subjects: 191
Study 28229567 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning Training Group (MTG)
Number of subjects: 30
Study 28229567 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening Training Group (ETG)
Number of subjects: 30
Study 28229567 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study 27002222 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week TI-MBSR intervention
Number of subjects: 45
Study 27002222 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 45
Study 23685264 — intervention group
Group type: EXPERIMENTAL
Intervention: Minding the Baby (MTB) intervention
Number of subjects: 0
Study 23685264 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21706345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal estriol plus pelvic floor rehabilitation
Number of subjects: 206
Study 21706345 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal estriol (control)
Number of subjects: 206
Study 20383852 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 296
Study 20383852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study 17913970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 750 mg alone
Number of subjects: 12
Study 17913970 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin 750 mg plus lanthanum carbonate 1 g three times daily with meals
Number of subjects: 12
Study 17196397 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious identification of masked primes during a 5-session perceptual learning task
Number of subjects: 0
Study 17196397 — intervention group
Group type: COMPARATOR
Intervention: Control group without equivalent perceptual learning
Number of subjects: 0
Study 17196397 — intervention group
Group type: COMPARATOR
Intervention: Ineffective masking in a control experiment
Number of subjects: 0
Study 15148337 — intervention group
Group type: EXPERIMENTAL
Intervention: MBL deficiency homozygotes
Number of subjects: 9245
Study 15148337 — intervention group
Group type: EXPERIMENTAL
Intervention: MBL deficiency heterozygotes
Number of subjects: 9245
Study 15148337 — intervention group
Group type: COMPARATOR
Intervention: Noncarriers
Number of subjects: 9245
Study 11389423 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic venous ulcer wound fluid (CVUWF, 300 microg protein/mL)
Number of subjects: 12
Study 11389423 — intervention group
Group type: COMPARATOR
Intervention: Bovine serum albumin (BSA)
Number of subjects: 12
Study 11389423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal fibroblasts from patients with CVI (du‐fb)
Number of subjects: 12
Study 11389423 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal fibroblasts from patients with reflux without ulcer (dr‐fb)
Number of subjects: 12
Study 11389423 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal fibroblasts (pu‐fb)
Number of subjects: 12
Study 11389423 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal fibroblasts (pr‐fb)
Number of subjects: 12
Study 9247759 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (+/‐ indapamide)
Number of subjects: 6000
Study 9247759 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo(s)
Number of subjects: 6000
Study 8093267 — intervention group
Group type: EXPERIMENTAL
Intervention: External hip protectors
Number of subjects: 447
Study 8093267 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hip protectors)
Number of subjects: 447
Study 3954127 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (N = 8)
Number of subjects: 15
Study 3954127 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane (N = 7)
Number of subjects: 15
Study 3954127 — intervention group
Group type: COMPARATOR
Intervention: Comparison of isoflurane and halothane
Number of subjects: 15
Study 11445756 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (0.3 g.kg(‐1) Cr monohydrate for 7 days)
Number of subjects: 20
Study 11445756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31582354 — intervention group
Group type: EXPERIMENTAL
Intervention: FCR chemoimmunotherapy
Number of subjects: 210
Study 29458447 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring urinary salt excretion using a self-measuring device for 4 weeks
Number of subjects: 78
Study 29458447 — intervention group
Group type: COMPARATOR
Intervention: Control group (urine salt excretion measured but results not disclosed)
Number of subjects: 78
Study 26804607 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical factors alone
Number of subjects: 2219
Study 26804607 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical plus echocardiographic findings
Number of subjects: 2219
Study 25373314 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐PBL (decision‐PBL)
Number of subjects: 81
Study 25373314 — intervention group
Group type: COMPARATOR
Intervention: Linear PBL
Number of subjects: 81
Study 25373314 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐PBL
Number of subjects: 81
Study 22578037 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelve-Step facilitation (TSF)
Number of subjects: 209
Study 22578037 — intervention group
Group type: COMPARATOR
Intervention: Integrated cognitive-behavioral therapy (ICBT)
Number of subjects: 209
Study 20082054 — intervention group
Group type: EXPERIMENTAL
Intervention: MAVIS nutrition trial
Number of subjects: 801
Study 17641254 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 470
Study 17641254 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 400 mg/day
Number of subjects: 470
Study 15938536 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lisinopril with indapamid
Number of subjects: 150
Study 15938536 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of egilok+hypothiaside
Number of subjects: 150
Study 15938536 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diroton+indap
Number of subjects: 150
Study 15938536 — intervention group
Group type: COMPARATOR
Intervention: Combination of cordipin-retard+hypothiaside
Number of subjects: 150
Study 15938536 — intervention group
Group type: COMPARATOR
Intervention: Combination of renitek-hypothiaside
Number of subjects: 150
Study 12117883 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA 4 mg/kg/h
Number of subjects: 0
Study 12117883 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA 8 mg/kg/h
Number of subjects: 0
Study 12117883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9935002 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker
Number of subjects: 54
Study 9935002 — intervention group
Group type: COMPARATOR
Intervention: No Pacemaker
Number of subjects: 54
Study 8697055 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine + Caffeine (E+C)
Number of subjects: 0
Study 8697055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2349371 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg naloxone intravenous injection
Number of subjects: 0
Study 2349371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 623171 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 0
Study 623171 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 0
Study 30856641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented lithium disilicate crown on a customized zirconia abutment (CEM)
Number of subjects: 34
Study 30856641 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-retained crown with a directly veneered zirconia abutment (SCREW)
Number of subjects: 34
Study 29390014 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 0
Study 29390014 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 0
Study 29390014 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AL and ASAQ
Number of subjects: 0
Study 26755382 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (40 mg) + 1-2 mL of 0.5% bupivacaine
Number of subjects: 63
Study 26755382 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine (control group)
Number of subjects: 63
Study 25266967 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic Sub‐Acromial Decompression (ASAD)
Number of subjects: 73
Study 23084166 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Enhancing Resiliency Amongst Students Experiencing Stress (ERASE‐Stress) - a manualized active 16‐session intervention
Number of subjects: 154
Study 23084166 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 154
Study 20110402 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment at a dose of 2 mg/m(2) per day until the onset of puberty for at least 2 years.
Number of subjects: 40
Study 20110402 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 40
Study 20110402 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 40
Study 17950163 — intervention group
Group type: EXPERIMENTAL
Intervention: Stomp Out Smokes (SOS) intervention for 24 weeks
Number of subjects: 70
Study 16392436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpan® (3 × 10 drops daily for 6 weeks)
Number of subjects: 0
Study 16392436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16392436 — intervention group
Group type: COMPARATOR
Intervention: Pumpan® and Placebo
Number of subjects: 0
Study 14579632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention through interviews conducted by Clinical Pastoral Education residents using the Brief Depression Scale, UCLA Loneliness Scale, and Index of Core Spiritual Experience.
Number of subjects: 118
Study 14579632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention through interviews assessing spirituality.
Number of subjects: 118
Study 14579632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention through interviews assessing ability to venture out of the house and family relationships.
Number of subjects: 118
Study 14579632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention through interviews assessing sense of meaning or purpose in life.
Number of subjects: 118
Study 14579632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention through interviews assessing spirituality demographics.
Number of subjects: 118
Study 11010944 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 298
Study 11010944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 11010944 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 298
Study 11010944 — intervention group
Group type: COMPARATOR
Intervention: Nonpregnant US women
Number of subjects: 298
Study 8858322 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (3 hours after PEG placement)
Number of subjects: 41
Study 8858322 — intervention group
Group type: COMPARATOR
Intervention: Delayed feeding (24 hours after PEG placement)
Number of subjects: 41
Study 1284345 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution (IHD)
Number of subjects: 20
Study 1284345 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine therapy only)
Number of subjects: 20
Study 6337663 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 10
Study 6337663 — intervention group
Group type: COMPARATOR
Intervention: Choline magnesium trisalicylate
Number of subjects: 10
Study 30888835 — intervention group
Group type: EXPERIMENTAL
Intervention: HCL AP therapy with the Control-IQ system
Number of subjects: 24
Study 30888835 — intervention group
Group type: COMPARATOR
Intervention: SAP therapy with remote monitoring
Number of subjects: 24
Study 29454311 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepitel Film (Arm A)
Number of subjects: 0
Study 29454311 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Arm B)
Number of subjects: 0
Study 27299483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 2.5 mg
Number of subjects: 83
Study 27299483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 83
Study 27299483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 83
Study 24972708 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 37
Study 24972708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 22864520 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalized infraclavicular lidocaine 2% 10 ml + ropivacaine 0.75% 20 ml ('long acting', n=90)
Number of subjects: 177
Study 22864520 — intervention group
Group type: COMPARATOR
Intervention: Adrenalized infraclavicular lidocaine 1.5% 30 ml + long-acting distal median, radial, and ulnar nerve blocks ('short acting', n=87)
Number of subjects: 177
Study 22864520 — intervention group
Group type: COMPARATOR
Intervention: Short acting group
Number of subjects: 177
Study 22864520 — intervention group
Group type: EXPERIMENTAL
Intervention: Long acting group
Number of subjects: 177
Study 20143047 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy alone
Number of subjects: 307
Study 20143047 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined drug and behavioral therapy
Number of subjects: 307
Study 20143047 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 307
Study 17650661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment (5‐10 mA, 80‐100 Hz, 30 min stimulation, once daily for 10 days)
Number of subjects: 100
Study 17650661 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine (10 mg/times, t.i.d, peros)
Number of subjects: 100
Study 17650661 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 100
Study 16037237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroxyacetone (DHA) followed by naphthoquinone, applied topically at bedtime
Number of subjects: 30
Study 16037237 — intervention group
Group type: COMPARATOR
Intervention: 3% DHA topically (previous studies)
Number of subjects: 30
Study 16037237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroxyacetone (DHA) followed by naphthoquinone
Number of subjects: 30
Study 12234851 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied one time per week
Number of subjects: 124
Study 12234851 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied two times per week
Number of subjects: 124
Study 12234851 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times per week
Number of subjects: 124
Study 12234851 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 124
Study 12234851 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (all dosing regimens)
Number of subjects: 124
Study 12234851 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 124
Study 9612628 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast medium
Number of subjects: 0
Study 9612628 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution
Number of subjects: 0
Study 9612628 — intervention group
Group type: EXPERIMENTAL
Intervention: Various antibiotics
Number of subjects: 0
Study 7817332 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine (lormetazepam, 2 mg)
Number of subjects: 6
Study 7817332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 2461823 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg ibuprofen
Number of subjects: 30
Study 2461823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30729456 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg bid
Number of subjects: 101
Study 30729456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 30025519 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach (DAA)
Number of subjects: 123
Study 30025519 — intervention group
Group type: COMPARATOR
Intervention: Direct transgluteal lateral approach
Number of subjects: 123
Study 27021357 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention package (GNS-led staff education, facility benchmarking, GNS resident review, multidisciplinary discussion)
Number of subjects: 1998